Clinical trial
Acute Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
NCT04042922 is registered in ClinicalTrials.gov with Massachusetts Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
- Lead sponsor
- Massachusetts Institute of Technology
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 19, 2019
- Completion date
- April 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.